Translate
About
Nasus Pharma Ltd. (AMEX:NSRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 25 2026
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update
Mar 16 2026
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold
Mar 9 2026
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
Mar 9 2026
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
Feb 20 2026
Nasus Pharma to Participate in Upcoming Investor Conferences
Recent Videos
Decided to get into pharma - This content was produced on behalf of Nasus Pharma (NYSE American:
Apr 21, 2026
Nasus Pharma (NSRX) | Biotech Resurgence Conference Replay
Apr 20, 2026
How to Invest in Nasus Pharma Ltd (NSRX) Step by Step
Mar 24, 2026
Life Sciences Virtual Investor Forum - Nasus Pharma Ltd. (NYSE: NSRX)
Mar 13, 2026
Financials
Revenue
$0
Market Cap
$27.52 M
EPS
-0.72